Source: Υπουργείο Υγείας (CY) Revision Year: 2023 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos Street, 3011 Limassol, Cyprus
Medotramol 37.5mg/325mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet. Yellow coloured, film-coated, elongated tablets with “325” embossing on one side of the tablet. |
Each film-coated tablet contains 37.5mg tramadol hydrochloride and 325mg paracetamol.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Paracetamol |
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
Tramadol |
Tramadol, a cyclohexanol derivative, is a centrally acting opioid analgesic. It is a non-selective pure agonist at μ, δ and κ opioid receptors with a higher affinity for the μ receptor. Other mechanisms which contribute to its analgesic effect are inhibition of neuronal reuptake of noradrenaline and enhancement of serotonin release. |
List of Excipients |
---|
Tablet core: Pregelatinised starch Film-coating: OPADRY yellow 15B82958 (hypromellose, titanium dioxide (E171), macrogol 400, yellow iron oxide (E172), polysorbate 80). |
Medotramol is packed in PVC/PVDC Alu blisters.
Boxes of 10, 20, 30, 50 and 100 tablets.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos Street, 3011 Limassol, Cyprus
M.L.: 022288
Date of first authorization: 20/04/2016
Date of latest renewal: 24/08/2020
Drug | Countries | |
---|---|---|
MEDOTRAMOL | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.